Article
CDKN3 alterations in the Kidney renal clear cell carcinoma: prognosis and immunotherapy efficacy
2025-08-04
Abstract excerpt
<title>Abstract</title> <p> Extensive evidence has unwrapped that Cyclin-dependent kinase inhibitor 3 (CDKN3) is involved in the modulation of many biological processes ranging extracellular matrix (ECM) degradation, invasion, and migration from regulation of immune responses in most malignancies. However, the impact of prognostic value and CDKN3-related immune response on kidney renal clear cell carcinoma (KIRC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f31f15db-37e9-5914-9c48-08ef92bdc533
- DOI
- 10.21203/rs.3.rs-7176947/v1
